Company Filing History:
1 out of 4 
1 out of 12,158 
1 out of 832,812 Years Active: 2003-2005
Title: Dietmar Kretzdorn: Innovator in Protein Expression Technologies
Introduction
Dietmar Kretzdorn, an accomplished inventor based in Leichlingen, Germany, has made significant contributions to the field of biotechnology with two notable patents. His work primarily focuses on enhancing protein expression in baculovirus vector systems, which holds promise for various applications in medical and agricultural biotechnology.
Latest Patents
Kretzdorn's latest patents revolve around the production of recombinant proteins, specifically the E2 subunit vaccine comprising the recombinant pestivirus E2 protein. The inventions provide innovative methods to increase protein expression in baculovirus expression systems. These methods involve selecting a recombinant baculovirus, growing insect cells in a controlled culture environment, and infecting the cells to achieve high concentrations of the desired proteins. The robust approaches described in his patents pinpoint methods to reach a final concentration of at least 100 µg/ml for recombinant pestivirus E2 proteins and at least 15 µg/ml for recombinant follicle stimulating hormone and its subunits.
Career Highlights
Throughout his career, Dietmar Kretzdorn has held positions in notable companies, contributing to advancements in his field. His experience, combined with his inventive mindset, has enabled him to develop methods that have potential implications for biologically relevant therapeutics and vaccines. His work showcases a commitment to improving protein expression techniques, which can enhance pharmaceutical production processes.
Collaborations
Kretzdorn has collaborated with esteemed colleagues including Dirk Franciscus Marinus Van De Wiel and Abraham Johannes De Smit. These partnerships have played a pivotal role in the development and refinement of his innovative techniques, fostering an exchange of ideas and expertise that bolsters the field of biotechnology.
Conclusion
Dietmar Kretzdorn's contributions to biotechnology highlight the importance of innovation in enhancing protein expression systems. His patents pave the way for future advancements in the production of recombinant proteins, which are vital for therapeutic applications. As the field continues to evolve, Kretzdorn's work stands as a testament to the power of creativity and collaboration in scientific progress.